GLAUKOS Corp
For the period ended Jun 30, 2024. Filed Aug 2, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2024 · Filed Aug 2, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. Other Information
Insider Trading Arrangements
On June 15, 2024, Gilbert H. Kliman, M.D., amember of the Company’s Board of Directors, terminated the 10b5-1 trading plan that he had entered into on March 15, 2024. On June 15, 2024, Dr. Kliman also adopted a new 10b5-1 trading plan (the “Trading Plan”). The Trading Plan is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Trading Plan provides for the potential sale of 10,000 shares of the Company’s common stock commencing September 16, 2024. The Trading Plan terminates on the earlier of May 23, 2025 or the date all shares are sold.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.